The 1,5-benzothiazepine
framework is well-known as a versatile
pharmacophore, and its derivatives have numerous biological activities.
Therefore, various synthetic routes to these important compounds have
already been investigated. However, in light of the increase in optically
active pharmaceuticals, it is of significance to also develop enantioselective
synthetic methods. Among various strategies, methods based on enantioselective
catalysis are generally efficient in both academia and industry with
respect to different factors such as atom or step economy, economic
reasons, and diversity-oriented synthesis. While various methodologies
had already been investigated until the 1990s, soon after the discovery
of marketed pharmaceuticals such as diltiazem, a blockbuster drug
containing a 1,5-benzothiazepine unit, additional catalytic strategies
also appeared. Thus, this Perspective provides an account of the progress
on enantioselective catalysis for the asymmetric synthesis of 1,5-benzothiazepine
derivatives.